{{Rsnum
|rsid=608995
|Gene=PGR
|Chromosome=11
|position=101035002
|Orientation=plus
|GMAF=0.2824
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=PGR
}}{{PMID|15632380}} Two SNPs in block 4 were associated with an increased risk of [[ovarian cancer]] among homozygous carriers as compared with noncarriers: [[rs1042838]] (PROGINS allele; odds ratio [OR] = 3.23, 95% confidence interval [CI] = 1.19 to 8.75, P = .022) and [[rs608995]] (minor allele; OR = 3.10, 95% CI = 1.63 to 5.89, P<.001)

{{PMID Auto
|PMID=20547493
|Title=Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach
|OA=1
}}

{{PMID Auto
|PMID=22121098
|Title=Worldwide distribution of allelic variation at the progesterone receptor locus and the incidence of female reproductive cancers
}}

{{PMID|18219286|OA=1
}} Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}